These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 10411546)

  • 1. Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.
    Dhodapkar MV; Steinman RM; Sapp M; Desai H; Fossella C; Krasovsky J; Donahoe SM; Dunbar PR; Cerundolo V; Nixon DF; Bhardwaj N
    J Clin Invest; 1999 Jul; 104(2):173-80. PubMed ID: 10411546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mature dendritic cells boost functionally superior CD8(+) T-cell in humans without foreign helper epitopes.
    Dhodapkar MV; Krasovsky J; Steinman RM; Bhardwaj N
    J Clin Invest; 2000 Mar; 105(6):R9-R14. PubMed ID: 10727452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells.
    Dhodapkar MV; Steinman RM; Krasovsky J; Munz C; Bhardwaj N
    J Exp Med; 2001 Jan; 193(2):233-8. PubMed ID: 11208863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection.
    Jonuleit H; Giesecke-Tuettenberg A; Tüting T; Thurner-Schuler B; Stuge TB; Paragnik L; Kandemir A; Lee PP; Schuler G; Knop J; Enk AH
    Int J Cancer; 2001 Jul; 93(2):243-51. PubMed ID: 11410873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cell gene therapy.
    Onaitis M; Kalady MF; Pruitt S; Tyler DS
    Surg Oncol Clin N Am; 2002 Jul; 11(3):645-60. PubMed ID: 12487060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines.
    Schnurr M; Galambos P; Scholz C; Then F; Dauer M; Endres S; Eigler A
    Cancer Res; 2001 Sep; 61(17):6445-50. PubMed ID: 11522639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocyte-derived dendritic cells generated after a short-term culture with IFN-alpha and granulocyte-macrophage colony-stimulating factor stimulate a potent Epstein-Barr virus-specific CD8+ T cell response.
    Santodonato L; D'Agostino G; Nisini R; Mariotti S; Monque DM; Spada M; Lattanzi L; Perrone MP; Andreotti M; Belardelli F; Ferrantini M
    J Immunol; 2003 May; 170(10):5195-202. PubMed ID: 12734367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paucity of functional T-cell memory to melanoma antigens in healthy donors and melanoma patients.
    Dhodapkar MV; Young JW; Chapman PB; Cox WI; Fonteneau JF; Amigorena S; Houghton AN; Steinman RM; Bhardwaj N
    Clin Cancer Res; 2000 Dec; 6(12):4831-8. PubMed ID: 11156242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody.
    Tacken PJ; de Vries IJ; Gijzen K; Joosten B; Wu D; Rother RP; Faas SJ; Punt CJ; Torensma R; Adema GJ; Figdor CG
    Blood; 2005 Aug; 106(4):1278-85. PubMed ID: 15878980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients.
    de Vries IJ; Lesterhuis WJ; Scharenborg NM; Engelen LP; Ruiter DJ; Gerritsen MJ; Croockewit S; Britten CM; Torensma R; Adema GJ; Figdor CG; Punt CJ
    Clin Cancer Res; 2003 Nov; 9(14):5091-100. PubMed ID: 14613986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity.
    Yang S; Vervaert CE; Burch J; Grichnik J; Seigler HF; Darrow TL
    Int J Cancer; 1999 Nov; 83(4):532-40. PubMed ID: 10508491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of dendritic cells pulsed with MAGE3, Survivin and B-cell maturation antigen mRNA for vaccination of multiple myeloma patients.
    Hobo W; Strobbe L; Maas F; Fredrix H; Greupink-Draaisma A; Esendam B; de Witte T; Preijers F; Levenga H; van Rees B; Raymakers R; Schaap N; Dolstra H
    Cancer Immunol Immunother; 2013 Aug; 62(8):1381-92. PubMed ID: 23728352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma.
    Thurner B; Haendle I; Röder C; Dieckmann D; Keikavoussi P; Jonuleit H; Bender A; Maczek C; Schreiner D; von den Driesch P; Bröcker EB; Steinman RM; Enk A; Kämpgen E; Schuler G
    J Exp Med; 1999 Dec; 190(11):1669-78. PubMed ID: 10587357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement of mature dendritic cells for efficient activation of influenza A-specific memory CD8+ T cells.
    Larsson M; Messmer D; Somersan S; Fonteneau JF; Donahoe SM; Lee M; Dunbar PR; Cerundolo V; Julkunen I; Nixon DF; Bhardwaj N
    J Immunol; 2000 Aug; 165(3):1182-90. PubMed ID: 10903715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing the exogenous antigen loading of monocyte-derived dendritic cells.
    Dieckmann D; Schultz ES; Ring B; Chames P; Held G; Hoogenboom HR; Schuler G
    Int Immunol; 2005 May; 17(5):621-35. PubMed ID: 15824067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting CD4(+) T-helper cells improves the induction of antitumor responses in dendritic cell-based vaccination.
    Aarntzen EH; De Vries IJ; Lesterhuis WJ; Schuurhuis D; Jacobs JF; Bol K; Schreibelt G; Mus R; De Wilt JH; Haanen JB; Schadendorf D; Croockewit A; Blokx WA; Van Rossum MM; Kwok WW; Adema GJ; Punt CJ; Figdor CG
    Cancer Res; 2013 Jan; 73(1):19-29. PubMed ID: 23087058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human dendritic cells, pulsed with either melanoma tumor cell lysates or the gp100 peptide(280-288), induce pairs of T-cell cultures with similar phenotype and lytic activity.
    Abdel-Wahab Z; DeMatos P; Hester D; Dong XD; Seigler HF
    Cell Immunol; 1998 May; 186(1):63-74. PubMed ID: 9637766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine.
    Banchereau J; Palucka AK; Dhodapkar M; Burkeholder S; Taquet N; Rolland A; Taquet S; Coquery S; Wittkowski KM; Bhardwaj N; Pineiro L; Steinman R; Fay J
    Cancer Res; 2001 Sep; 61(17):6451-8. PubMed ID: 11522640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma.
    Goldszmid RS; Idoyaga J; Bravo AI; Steinman R; Mordoh J; Wainstok R
    J Immunol; 2003 Dec; 171(11):5940-7. PubMed ID: 14634105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single injection of CD34+ progenitor-derived dendritic cell vaccine can lead to induction of T-cell immunity in patients with stage IV melanoma.
    Palucka AK; Dhodapkar MV; Paczesny S; Burkeholder S; Wittkowski KM; Steinman RM; Fay J; Banchereau J
    J Immunother; 2003; 26(5):432-9. PubMed ID: 12973032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.